"People being treated for advanced skin and lung cancer lived longer if they had received a Moderna or Pfizer COVID-19 vaccine, according to new research published in the journal . Both vaccines work using mRNA, which prompts cells to make a virus-like protein that triggers a useful immune response"
"The team analyzed records from almost 1,000 advanced cancer patients at Houston's MD Anderson Cancer Center, comparing outcomes between people that had received one of the two COVID-19 mRNA vaccines and those who hadn't. They found that lung cancer patients vaccinated with the Pfizer or Moderna shot lived almost twice as long after starting cancer treatment. Patients with aggressive melanoma who received an mRNA vaccine also showed improved outcomes, but people in that group lived for so long their average"
People treated for advanced lung and skin cancers who had received Moderna or Pfizer COVID-19 mRNA vaccines lived longer than unvaccinated patients in a review of nearly 1,000 MD Anderson records. The vaccines stimulate cells to make virus-like proteins through mRNA, prompting a broad immune response that enhances subsequent checkpoint immunotherapy. Lung cancer patients vaccinated with mRNA shots lived almost twice as long after starting cancer treatment, and patients with aggressive melanoma showed improved outcomes. Non-mRNA vaccines did not produce the same effect. The greatest benefit occurred when vaccination happened within 100 days of beginning checkpoint therapy and in cancers less likely to respond.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]